Whether adjuvant immunotherapy should continue to be used in patients with triple-negative breast cancer who respond to neoadjuvant immunotherapy.

Saved in:
Bibliographic Details
Title: Whether adjuvant immunotherapy should continue to be used in patients with triple-negative breast cancer who respond to neoadjuvant immunotherapy.
Authors: Li ZD; Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China., Ren TY, Wang YS, Bi Z
Source: International journal of surgery (London, England) [Int J Surg] 2026 Feb 01; Vol. 112 (2), pp. 2243-2245. Date of Electronic Publication: 2025 Nov 10.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101228232 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-9159 (Electronic) Linking ISSN: 17439159 NLM ISO Abbreviation: Int J Surg Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1743-9159
DOI:10.1097/JS9.0000000000003621